Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.280
-0.110 (-7.91%)
At close: Apr 21, 2026, 4:00 PM EDT
1.300
+0.020 (1.56%)
After-hours: Apr 21, 2026, 7:19 PM EDT

Traws Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.790.230.230.230.23
Revenue Growth (YoY)
1134.51%----2.17%
Gross Profit
2.790.230.230.230.23
Selling, General & Admin
8.5212.299.098.459.43
Research & Development
12.14130.3111.4311.417.3
Total Operating Expenses
20.67142.620.5219.8516.72
Operating Income
-17.88-142.37-20.3-19.63-16.5
Total Non-Operating Income (Expense)
27.05-24.151.350.660.33
Pretax Income
9.17-166.52-18.95-18.96-16.16
Net Income
6.87-54.67-18.95-18.96-16.16
Net Income to Common
6.87-54.67-18.95-18.96-16.16
Shares Outstanding (Basic)
8212117
Shares Outstanding (Diluted)
8212117
Shares Change (YoY)
439.48%84.94%-95.98%24.21%45.07%
EPS (Basic)
0.83-35.21-22.57-0.91-0.96
EPS (Diluted)
0.82-35.21-22.57-0.91-0.96
Shares Outstanding
11.766.610.8420.9320.9
Free Cash Flow
-18.19-29.79-17.95-16.29-19.49
Free Cash Flow Per Share
-2.17-19.19-21.38-0.78-1.16
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-640.68%-62997.30%-8981.42%-8684.51%-7299.12%
Profit Margin
328.67%-73682.70%-8384.07%-8391.15%-7151.77%
FCF Margin
-651.79%-13182.30%-7940.71%-7209.73%-8622.57%
EBITDA
-17.81-142.36-20.28-19.61-16.48
EBITDA Margin
-638.50%-62992.00%-8974.34%-8678.32%-7292.92%
EBIT
-17.88-142.37-20.3-19.63-16.5
EBIT Margin
-640.68%-62997.30%-8981.42%-8684.51%-7299.12%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q